Perceived Health Concerns of Child Hand Nicotine Levels Among Parental Smokers of Young Children.

What Was Tested

This observational study looks at Therapeutic nicotine (patch, non-peptide).

The objective was to assess health concerns of parental smokers and their readiness to quit after being given hypothetically high and low child HN levels.

After being presented with each result, parents reported their readiness to quit smoking (range = 0-10) and general concern about the results, concern that smoking would affect their child's health, and perception of how often their child would get sick (ranges = 0-3). t tests were performed to compare sample means.

Why It Was Studied

Handwipe nicotine (HN) levels can serve as biomarkers of children's exposure to thirdhand smoke (THS) and may be an innovative smoking cessation tool.

Who Took Part

The age groups tagged for this paper are infants, young children, children and adults, both men and women.

Participants were parental smokers/vapers (N = 89) who lived with their 0- to 11-year-old children and who were participating in a THS observational trial.

Parents were presented with hypothetical child HN levels: high result of more than 200 ng/wipe and low result of less than 10 ng/wipe.

What Was Measured

Handwipe nicotine (HN) levels can serve as biomarkers of children's exposure to thirdhand smoke (THS) and may be an innovative smoking cessation tool.

PubMed files the paper under topics including Parents, Nicotine, Tobacco Smoke Pollution, Smoking Cessation and Smokers.

What This Means in Plain Language

This is an observational study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2025 (Hospital pediatrics), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.